Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. (Angiotech Pharmaceuticals) is a global medical device and specialty pharmaceutical company. The company is engaged in the development, discovery and marketing of medical products and novel technologies for diseases and complications that require medical implants and surgical interventions. It operates in two business segments, namely, Pharmaceutical Technologies and Medical Products segment. The company markets and sells its products through two specialty direct sales organizations. It carries out its operations in the US, Europe and other regions across the world. Angiotech Pharmaceuticals is headquartered in Vancouver, Canada.